Tag archive for ‘Keffi Group’
Gali Weinreb On Thursday, October 2nd, 2014

VBL Therapeutics raises $40 million in revived Nasdaq IPO

– After the fiasco of the failed IPO in August, the drug development company scaled down the offering. VBL Therapeutics has raised $40 million at a company value of $120 million in a revived IPO on Nasdaq. More...

Wordpress site Developed by Fixing WordPress Problems